CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

KLRSKalaris Therapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $2.89 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$68.80M
CountryUSA
RECENT INSIDER TRADES
  • 2026-05-22 · AKKARAJU SRINIVAS (Director) · OTHER
  • 2026-05-22 · AKKARAJU SRINIVAS (Director) · BUY
  • 2026-03-23 · Hagen Brett R (Chief Accounting Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders57
Shares held18,323,771
Value$75.76M
Percent of shares outstanding76.97%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Kalaris Therapeutics, Inc. (KLRS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit